Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Peritoneal sarcomatosis from uterine sarcoma is a rare disease with no effective treatment and poor prognosis. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has successful results in peritoneal carcinomatosis from gastrointestinal/gynecological origins. We show that CRS/HIPEC is safe, feasible, and may benefit selected patients with peritoneal sarcomatosis from uterine sarcoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986004 | PMC |
| http://dx.doi.org/10.1002/ccr3.1491 | DOI Listing |
Publication Analysis
Top Keywords
peritoneal sarcomatosis
12
sarcomatosis uterine
12
uterine sarcoma
12
cytoreductive surgery
8
surgery hyperthermic
8
hyperthermic intraperitoneal
8
intraperitoneal chemotherapy
8
patients peritoneal
8
chemotherapy patients
4
peritoneal
4